Clinical Trial Update: Cetuximab With Radiotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck in Chinese Subjects [Phase 3]

View source ↗

Summary

This Phase 3 trial update reports the results of adding cetuximab to radiotherapy for locally advanced head and neck squamous cell carcinoma in Chinese patients…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Cetuximab (cetuximab)

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Squamous Cell Carcinoma of the Head and Neck | Phase 3 | Status: COMPLETED | Results posted: 2012-08-14